The NRC has finalized that Ra-223 “Alpharadin” will be ruled a 35.300 radiopharmaceutical and for those institutions already licensed under this section with AU granted full 35.300 status – No Amendment needed.
Learn More
NRC Rules Ra-223 is 35.300
